94TH GENERAL ASSEMBLY
State of Illinois
2005 and 2006
SB2589

 

Introduced 1/20/2006, by Sen. John J. Millner

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/204   from Ch. 56 1/2, par. 1204

    Amends the Illinois Controlled Substances Act. Provides that Salvia divinorum is a Schedule I controlled substance.


LRB094 18565 RLC 53900 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY

 

 

A BILL FOR

 

SB2589 LRB094 18565 RLC 53900 b

1     AN ACT concerning criminal law.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Illinois Controlled Substances Act is
5 amended by changing Section 204 as follows:
 
6     (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7     Sec. 204. (a) The controlled substances listed in this
8 Section are included in Schedule I.
9     (b) Unless specifically excepted or unless listed in
10 another schedule, any of the following opiates, including their
11 isomers, esters, ethers, salts, and salts of isomers, esters,
12 and ethers, whenever the existence of such isomers, esters,
13 ethers and salts is possible within the specific chemical
14 designation:
15         (1) Acetylmethadol;
16         (1.1) Acetyl-alpha-methylfentanyl
17     (N-[1-(1-methyl-2-phenethyl)-
18     4-piperidinyl]-N-phenylacetamide);
19         (2) Allylprodine;
20         (3) Alphacetylmethadol, except
21     levo-alphacetylmethadol (also known as levo-alpha-
22     acetylmethadol, levomethadyl acetate, or LAAM);
23         (4) Alphameprodine;
24         (5) Alphamethadol;
25         (6) Alpha-methylfentanyl
26     (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
27     propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
28     propanilido) piperidine;
29         (6.1) Alpha-methylthiofentanyl
30     (N-[1-methyl-2-(2-thienyl)ethyl-
31     4-piperidinyl]-N-phenylpropanamide);
32         (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);

 

 

SB2589 - 2 - LRB094 18565 RLC 53900 b

1         (7) 1-methyl-4-phenyl-4-proprionoxypiperidine (MPPP);
2         (7.1) PEPAP
3     (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
4         (8) Benzethidine;
5         (9) Betacetylmethadol;
6         (9.1) Beta-hydroxyfentanyl
7     (N-[1-(2-hydroxy-2-phenethyl)-
8     4-piperidinyl]-N-phenylpropanamide);
9         (10) Betameprodine;
10         (11) Betamethadol;
11         (12) Betaprodine;
12         (13) Clonitazene;
13         (14) Dextromoramide;
14         (15) Diampromide;
15         (16) Diethylthiambutene;
16         (17) Difenoxin;
17         (18) Dimenoxadol;
18         (19) Dimepheptanol;
19         (20) Dimethylthiambutene;
20         (21) Dioxaphetylbutyrate;
21         (22) Dipipanone;
22         (23) Ethylmethylthiambutene;
23         (24) Etonitazene;
24         (25) Etoxeridine;
25         (26) Furethidine;
26         (27) Hydroxpethidine;
27         (28) Ketobemidone;
28         (29) Levomoramide;
29         (30) Levophenacylmorphan;
30         (31) 3-Methylfentanyl
31     (N-[3-methyl-1-(2-phenylethyl)-
32     4-piperidyl]-N-phenylpropanamide);
33         (31.1) 3-Methylthiofentanyl
34     (N-[(3-methyl-1-(2-thienyl)ethyl-
35     4-piperidinyl]-N-phenylpropanamide);
36         (32) Morpheridine;

 

 

SB2589 - 3 - LRB094 18565 RLC 53900 b

1         (33) Noracymethadol;
2         (34) Norlevorphanol;
3         (35) Normethadone;
4         (36) Norpipanone;
5         (36.1) Para-fluorofentanyl
6     (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
7     4-piperidinyl]propanamide);
8         (37) Phenadoxone;
9         (38) Phenampromide;
10         (39) Phenomorphan;
11         (40) Phenoperidine;
12         (41) Piritramide;
13         (42) Proheptazine;
14         (43) Properidine;
15         (44) Propiram;
16         (45) Racemoramide;
17         (45.1) Thiofentanyl
18     (N-phenyl-N-[1-(2-thienyl)ethyl-
19     4-piperidinyl]-propanamide);
20         (46) Tilidine;
21         (47) Trimeperidine;
22         (48) Beta-hydroxy-3-methylfentanyl (other name:
23     N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
24     N-phenylpropanamide).
25     (c) Unless specifically excepted or unless listed in
26 another schedule, any of the following opium derivatives, its
27 salts, isomers and salts of isomers, whenever the existence of
28 such salts, isomers and salts of isomers is possible within the
29 specific chemical designation:
30         (1) Acetorphine;
31         (2) Acetyldihydrocodeine;
32         (3) Benzylmorphine;
33         (4) Codeine methylbromide;
34         (5) Codeine-N-Oxide;
35         (6) Cyprenorphine;
36         (7) Desomorphine;

 

 

SB2589 - 4 - LRB094 18565 RLC 53900 b

1         (8) Diacetyldihydromorphine (Dihydroheroin);
2         (9) Dihydromorphine;
3         (10) Drotebanol;
4         (11) Etorphine (except hydrochloride salt);
5         (12) Heroin;
6         (13) Hydromorphinol;
7         (14) Methyldesorphine;
8         (15) Methyldihydromorphine;
9         (16) Morphine methylbromide;
10         (17) Morphine methylsulfonate;
11         (18) Morphine-N-Oxide;
12         (19) Myrophine;
13         (20) Nicocodeine;
14         (21) Nicomorphine;
15         (22) Normorphine;
16         (23) Pholcodine;
17         (24) Thebacon.
18     (d) Unless specifically excepted or unless listed in
19 another schedule, any material, compound, mixture, or
20 preparation which contains any quantity of the following
21 hallucinogenic substances, or which contains any of its salts,
22 isomers and salts of isomers, whenever the existence of such
23 salts, isomers, and salts of isomers is possible within the
24 specific chemical designation (for the purposes of this
25 paragraph only, the term "isomer" includes the optical,
26 position and geometric isomers):
27         (1) 3,4-methylenedioxyamphetamine
28     (alpha-methyl,3,4-methylenedioxyphenethylamine,
29     methylenedioxyamphetamine, MDA);
30         (1.1) Alpha-ethyltryptamine
31     (some trade or other names: etryptamine;
32     MONASE; alpha-ethyl-1H-indole-3-ethanamine;
33     3-(2-aminobutyl)indole; a-ET; and AET);
34         (2) 3,4-methylenedioxymethamphetamine (MDMA);
35         (2.1) 3,4-methylenedioxy-N-ethylamphetamine
36     (also known as: N-ethyl-alpha-methyl-

 

 

SB2589 - 5 - LRB094 18565 RLC 53900 b

1     3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
2     and MDEA);
3         (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
4         (4) 3,4,5-trimethoxyamphetamine (TMA);
5         (5) (Blank);
6         (6) Diethyltryptamine (DET);
7         (7) Dimethyltryptamine (DMT);
8         (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
9         (9) Ibogaine  (some trade and other names:
10     7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
11     6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
12     indole; Tabernanthe iboga);
13         (10) Lysergic acid diethylamide;
14         (10.5) Salvia divinorum;
15         (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
16         (12) Peyote (meaning all parts of the plant presently
17     classified botanically as Lophophora williamsii williemaii
18     Lemaire, whether growing or not, the seeds thereof, any
19     extract from any part of that plant, and every compound,
20     manufacture, salts, derivative, mixture, or preparation of
21     that plant, its seeds or extracts);
22         (13) N-ethyl-3-piperidyl benzilate (JB 318);
23         (14) N-methyl-3-piperidyl benzilate;
24         (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
25     (also known as N-hydroxy-alpha-methyl-
26     3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
27         (15) Parahexyl; some trade or other names:
28     3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
29     dibenzo (b,d) pyran; Synhexyl;
30         (16) Psilocybin;
31         (17) Psilocyn;
32         (18) Alpha-methyltryptamine (AMT);
33         (19) 2,5-dimethoxyamphetamine
34     (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
35         (20) 4-bromo-2,5-dimethoxyamphetamine
36     (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;

 

 

SB2589 - 6 - LRB094 18565 RLC 53900 b

1     4-bromo-2,5-DMA);
2         (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
3     Some trade or other names: 2-(4-bromo-
4     2,5-dimethoxyphenyl)-1-aminoethane;
5     alpha-desmethyl DOB, 2CB, Nexus;
6         (21) 4-methoxyamphetamine
7     (4-methoxy-alpha-methylphenethylamine;
8     paramethoxyamphetamine; PMA);
9         (22) (Blank);
10         (23) Ethylamine analog of phencyclidine.
11     Some trade or other names:
12     N-ethyl-1-phenylcyclohexylamine,
13     (1-phenylcyclohexyl) ethylamine,
14     N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
15         (24) Pyrrolidine analog of phencyclidine. Some trade
16     or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
17     PHP;
18         (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
19         (26) 2,5-dimethoxy-4-ethylamphetamine
20     (another name: DOET);
21         (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
22     (another name: TCPy);
23         (28) (Blank);
24         (29) Thiophene analog of phencyclidine (some trade
25     or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
26     2-thienyl analog of phencyclidine; TPCP; TCP);
27         (30) Bufotenine (some trade or other names:
28     3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
29     3-(2-dimethylaminoethyl)-5-indolol;
30     5-hydroxy-N,N-dimethyltryptamine;
31     N,N-dimethylserotonin; mappine).
32     (e) Unless specifically excepted or unless listed in
33 another schedule, any material, compound, mixture, or
34 preparation which contains any quantity of the following
35 substances having a depressant effect on the central nervous
36 system, including its salts, isomers, and salts of isomers

 

 

SB2589 - 7 - LRB094 18565 RLC 53900 b

1 whenever the existence of such salts, isomers, and salts of
2 isomers is possible within the specific chemical designation:
3         (1) mecloqualone;
4         (2) methaqualone; and
5         (3) gamma hydroxybutyric acid.
6     (f) Unless specifically excepted or unless listed in
7 another schedule, any material, compound, mixture, or
8 preparation which contains any quantity of the following
9 substances having a stimulant effect on the central nervous
10 system, including its salts, isomers, and salts of isomers:
11         (1) Fenethylline;
12         (2) N-ethylamphetamine;
13         (3) Aminorex (some other names:
14     2-amino-5-phenyl-2-oxazoline; aminoxaphen;
15     4-5-dihydro-5-phenyl-2-oxazolamine) and its
16     salts, optical isomers, and salts of optical isomers;
17         (4) Methcathinone (some other names:
18     2-methylamino-1-phenylpropan-1-one;
19     Ephedrone; 2-(methylamino)-propiophenone;
20     alpha-(methylamino)propiophenone; N-methylcathinone;
21     methycathinone; Monomethylpropion; UR 1431) and its
22     salts, optical isomers, and salts of optical isomers;
23         (5) Cathinone (some trade or other names:
24     2-aminopropiophenone; alpha-aminopropiophenone;
25     2-amino-1-phenyl-propanone; norephedrone);
26         (6) N,N-dimethylamphetamine (also known as:
27     N,N-alpha-trimethyl-benzeneethanamine;
28     N,N-alpha-trimethylphenethylamine);
29         (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
30     4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
31     (g) Temporary listing of substances subject to emergency
32 scheduling. Any material, compound, mixture, or preparation
33 that contains any quantity of the following substances:
34         (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
35     (benzylfentanyl), its optical isomers, isomers, salts,
36     and salts of isomers;

 

 

SB2589 - 8 - LRB094 18565 RLC 53900 b

1         (2) N-[1(2-thienyl)
2    methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
3    its optical isomers, salts, and salts of isomers.
4 (Source: P.A. 90-382, eff. 8-15-97; 91-714, eff. 6-2-00;
5 revised 10-18-05.)